Allergy/Asthma News

Atopic dermatitis in children may be associated with metabolic syndrome and nonalcoholic fatty liver disease, according to a study.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

A joint task force has published an updated, evidence-based practice parameter for diagnosing and treating anaphylaxis in Annals of Allergy, Asthma & Immunology.

The end of the federal student loan payment pause, a reprieve that lasted more than 3 years due to the COVID-19 pandemic, marks a critical juncture for millions of Americans, especially for physicians.

Patients with severe depression faced increased odds for cough, wheezing, exertional dyspnea, asthma and COPD vs. individuals without depression, according to results published in Respiratory Medicine.

The prevalence of severe persistent asthma among patients with asthma significantly ranges across the United States, from 19.6% in New Mexico to 31.9% in Alaska, according to a study published in Annals of Allergy, Asthma & Immunology.

Abrocitinib downregulated genes associated with inflammation, epidermal hyperplasia, and T helper 2 and T helper 22 responses in the skin of patients with moderate to severe atopic dermatitis, according to a study published in Allergy.

Although 11.3% of households surveyed reported drug hypersensitivities, the prevalence of different hypersensitivities varied significantly, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Climatic hazards associated with greenhouse gas emissions may exacerbate atopic dermatitis, including severity and flares, while increasing its prevalence and related health care utilization, according to a review published in Allergy.

Researchers characterized the use of dupilumab among a cohort of patients with asthma, chronic rhinosinusitis with nasal polyps or both as persistent in a study published in Annals of Allergy, Asthma & Immunology.